Adapting the Penny Chatbot for Perinatal OUD Patients: COPILOT
Recruiting
N/A
Interventional Study
Perinatal Opioid Use Disorder
Opioid Use Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Sex
- Female
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 20 (estimated)
- Sponsor
- University of Pennsylvania · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To address both loneliness and engagement in perinatal and OUD care among perinatal women, the investigators plan to adapt an existing texting support chatbot, Penny, to make it appropriate for use by women who are pregnant and postpartum and dealing with OUD. The newly adapted chatbot, Penny COPILOT, will allow for two way short message service (SMS) messaging to respond appropriately and accurat…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Biological females who are currently pregnant or within 6 weeks postpartum.
* Able to read, write, and speak English at a 6th grade level.
* Diagnosed and receiving treatment for, or willing to receive treatment for opioid use disorder.
* Receiving prenatal care and OUD care a…
Contacts